Manage — Microdystrophin Gene Transfer (DMD)
Edit fields and add or remove reviews, snapshots, outcomes, evidence claims, and documents.
Asset fields
Reviews
- Industry · mixed/medium · Gene therapy advisor
Snapshots
- Q2 2025
- Q1 2025
Outcomes
- Clinical entry · 2025-01-05
Evidence claims
- regulatory / Accelerated Approval
- scientific / Supporting Evidence
- translational / Manufacturing
Applications
None yet.
Funding events
- tranche · USD1,500,000 · 2025-02-01
Documents
Application PDFs, reviewer forms, decks — attached as evidence (max 25 MB).
No documents yet.